Similarly, Shanghai Maling invested in Silver Fern Farms in 2016 at a time when the company was under significant financial pressure. Just last week it was announced that Yili had signed a conditional deal to acquire Westland for $588 million. Westland ran a competitive process and Yili made the most compelling offer to Westland and its farmers.
Agilent had sued Twist, CEO and Cofounder Emily Leproust, and several other individuals in 2016 in Santa Clara (California) Superior Court, alleging theft of trade secrets related to DNA oligonucleotide synthesis. Last week, the firms announced a settlement where Twist would make a one-time payment to Agilent of $22.5 million in exchange for full relief of the claims, with no admission of liability or wrongdoing by Twist.
Jay Flatley has become chairman of the board of directors at Illumina. Until the end of 2019, he was executive chairman, and from 1999 until mid-2016, he was Illumina's CEO. Previously, he was president and CEO of Molecular Dynamics, now part of GE Healthcare. Before that, he was VP of engineering and strategic planning at Plexus Computers, executive VP at Manning Technologies, and held various positions at Spectra Physics.
Twist Bioscience, a synthetic DNA manufacturer serving a wide range of industries, has announced reaching a settlement agreement regarding a trade secret lawsuit filed by Agilent Technologies in 2016. Under the terms of the agreement, Twist would admit no liability or wrongdoing, and Agilent would fully release the claims being made. Twist will pay Agilent $22.5 million in the agreement.